Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Another Day, Another Biotech Dilution

Dilution is a way of life for investors in development stage biotechs --  a painful reminder of the costs associated with developing promising new treatments. We have seen a series of high-profile dilutions this month, and in this video health care analyst David Williamson touches on all of them, but focuses in on Aeterna Zentaris action from last week.

Many investors are attracted to Aeterna Zentaris and biotechs like it since they hold the allure of substantial short-term gains. But there is more than one approach to building long-term wealth and retiring well. In our free report "3 Stocks That Will Help You Retire Rich," we reveal some stocks that could help you as well as some winning wealth-building strategies. Click here to keep reading.

Dave Williamson has no positions in the stocks mentioned above. Max Macaluso has no positions in the stocks mentioned above. The Motley Fool has no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Read/Post Comments (0) | Recommend This Article (3)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2060501, ~/Articles/ArticleHandler.aspx, 10/21/2016 9:48:24 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,057.92 -104.43 -0.57%
S&P 500 2,131.78 -9.56 -0.45%
NASD 5,232.59 -9.25 -0.18%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/21/2016 9:32 AM
AEZS $4.88 Down -0.01 -0.20%
Aeterna Zentaris CAPS Rating: *****
CTIC $0.39 Down -0.01 -3.60%
CTI BioPharma CAPS Rating: **
HEB $1.06 Down +0.00 +0.00%
Hemispherx BioPhar… CAPS Rating: *
KERX $4.54 Down -0.10 -2.16%
Keryx Biopharmaceu… CAPS Rating: **